No recent analyst price targets found for RVVTF.
Latest News for RVVTF
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today an update on its ongoing research study evaluating Bucillamine as a potential treatment for nerve agent exposure. The…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for RVVTF.
Senate Trading
No Senate trades found for RVVTF.
U.S. House Trading
No House trades found for RVVTF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.